Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 4:14 pm Purchase | 2022-12-31 | 13G | Vaxcyte, Inc. PCVX | Carlyle Group Inc. CG | 2,070,724 2.600% | 2,070,724 (New Position) | Filing History |
| 2023-02-10 12:06 pm Purchase | 2022-12-31 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 5,974,139 7.600% | 1,727,475 (+40.68%) | Filing History |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 10,169,281 12.875% | 2,294,931 (+29.14%) | Filing History |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | Vaxcyte, Inc. PCVX | The Vanguard Group | 6,613,666 8.370% | 3,479,380 (+111.01%) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 5,105,370 6.500% | 2,316,363 (+83.05%) | Filing History |
| 2022-03-09 5:18 pm Purchase | 2022-02-28 | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 2,789,007 5.000% | 11,960 (+0.43%) | Filing History |
| 2022-02-14 6:44 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | Longitude Venture Partners II L.P. | 1,616,070 3.100% | 1,616,070 (New Position) | Filing History |
| 2022-02-14 4:17 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | Abingworth LLP | 4,183,716 7.900% | 14,998 (+0.36%) | Filing History |
| 2022-02-14 06:19 am Sale | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | Roche Finance Ltd | 2,334,113 4.400% | -253,641 (-9.80%) | Filing History |
| 2022-02-10 5:24 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 4,246,664 8.000% | 49,886 (+1.19%) | Filing History |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | The Vanguard Group | 3,134,286 5.940% | 3,134,286 (New Position) | Filing History |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 7,874,350 14.917% | 231,945 (+3.03%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 2,777,047 5.300% | 2,777,047 (New Position) | Filing History |
| 2022-01-18 5:22 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | TPG GP A, LLC | 4,149,544 7.900% | 4,149,544 (New Position) | Filing History |
| 2021-03-30 4:43 pm Purchase | 2021-03-24 | 13G | Vaxcyte, Inc. PCVX | RA Capital Management, L.P. | 3,865,808 7.530% | 155,109 (+4.18%) | Filing History |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | RA Capital Management, L.P. | 3,710,699 7.300% | -1,778,482 (-32.40%) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | Abingworth LLP | 4,168,718 8.200% | 4,168,718 (New Position) | Filing History |
| 2021-02-16 07:02 am Purchase | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | Roche Finance Ltd | 2,587,754 5.100% | 2,587,754 (New Position) | Filing History |
| 2021-02-12 5:12 pm Purchase | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | Longitude Capital Partners II LLC | 3,108,780 6.100% | 3,108,780 (New Position) | Filing History |
| 2021-02-12 4:57 pm Sale | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | TPG Group Holdings (SBS) Advisors Inc. | 4,729,278 9.300% | -427,275 (-8.29%) | Filing History |